Institutional Ownership
Aclaris Therapeutics Inc
CUSIP 00461U105COMACRSQ1 2026
Institutional Holders
131
13F filers
Shares Held
101.67M
Aggregate institutional
Institutional Value
$372.91M
Q1 2026
Net New Holders
+13
28 new · 15 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions28
Increased41
Decreased40
Sold out15
Institutional Holders
131 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bml Capital Management, LLC | 14.25M | $53.44M | 0 | Held |
| 2 | Deep Track Capital, LP | 9.35M | $35.04M | +9.35M | New |
| 3 | Blackrock, Inc. | 7.41M | $27.78M | +602.2K | Added |
| 4 | Ra Capital Management, L.P. | 6.80M | $25.52M | +6.80M | New |
| 5 | Vivo Capital, LLC | 6.67M | $25.00M | −2.22M | Reduced |
| 6 | Frazier Life Sciences Management, L.P. | 4.93M | $18.47M | +4.93M | New |
| 7 | Rock Springs Capital Management LP | 4.47M | $16.77M | +18.9K | Added |
| 8 | Decheng Capital LLC | 4.04M | $15.16M | 0 | Held |
| 9 | Adage Capital Partners Gp, L.L.C. | 3.87M | $14.52M | +500.0K | Added |
| 10 | Balyasny Asset Management L.P. | 3.36M | $12.60M | +3.36M | New |
121 more institutional holders on Premium
See every fund holding Aclaris Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders